COMPLETED

Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Official Title

Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.

Quick Facts

Study Start:2025-01-09
Study Completion:2025-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06773013

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pediatric subjects between the ages of 12 to 21 years
  2. * Present with symptoms of nasal congestion for 1 month or more prior to treatment
  3. * Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening
  1. * Head, nasal or sinus surgery within 3 months
  2. * Sinus infection diagnosed within the last month, or rhinitis medicamentosa
  3. * Documented history of nasal polyposis or mass
  4. * Pregnancy

Contacts and Locations

Principal Investigator

Alan Greene, MD
PRINCIPAL_INVESTIGATOR
Crescendo MD

Study Locations (Sites)

Crescendo MD
Portola Valley, California, 94028
United States

Collaborators and Investigators

Sponsor: Third Wave Therapeutics

  • Alan Greene, MD, PRINCIPAL_INVESTIGATOR, Crescendo MD

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-09
Study Completion Date2025-03-30

Study Record Updates

Study Start Date2025-01-09
Study Completion Date2025-03-30

Terms related to this study

Additional Relevant MeSH Terms

  • Nasal Congestion and Inflammations